bims-mitdis Biomed News
on Mitochondrial disorders
Issue of 2026–11–22
sixty-four papers selected by
Catalina Vasilescu, Helmholz Munich



  1. J Clin Invest. 2026 Nov 19. pii: e207965. [Epub ahead of print]
      Mitochondrial failure is a convergent driver of neuronal aging and neurodegeneration, yet upstream factors that link age-associated changes to mitochondrial homeostasis remain incompletely defined. Melatonin, which is synthesized within neuronal mitochondria, declines with age and is further exacerbated in several neurodegenerative disorders. Here we show that endogenous melatonin is required to maintain cerebral mitochondrial biogenesis and mitochondrial quality through the SIRT1/PGC-1α signaling axis. Across young (8-week), adult (20-week), and middle-aged (1-year) mouse brains, aging was associated with reduced SIRT1/PGC-1α, decreased mtDNA copy number, and diminished abundance of oxidative phosphorylation proteins. Human hippocampal samples from older donors similarly exhibited reduced SIRT1/PGC-1α but retained mitochondrial protein abundance while accumulating oxidatively damaged mitochondria and showing reduced LC3B, consistent with impaired mitochondrial quality control. In aralkylamine N-acetyltransferase knockout (AANAT-KO) mice, endogenous melatonin deficiency suppressed SIRT1/PGC-1α, NRF1, and TFAM in an age-dependent manner, reduced mtDNA and mitochondrial transcript abundance, lowered mitochondrial protein levels, and increased mitochondrial oxidative damage. Melatonin supplementation restored the biogenesis program, increased mtDNA and mitochondrial transcripts, and rescued respiratory chain protein abundance. Finally, mitochondrial transplantation experiments indicated that mitochondrial quality contributes to neuronal integrity. Melatonin-deficient mitochondria induced neurite degeneration in wild-type neurons, whereas wild-type mitochondria rescued neurite architecture and improved survival in melatonin-deficient neurons. Together, these findings identify endogenous melatonin as a regulator of cerebral mitochondrial biogenesis and suggest that melatonin decline contributes to mitochondrial-mediated neuritic degeneration and neuronal loss.
    Keywords:  Aging; Mitochondria; Neurodegeneration; Neuroscience
    DOI:  https://doi.org/10.1172/JCI207965
  2. Sci Adv. 2026 Nov 20. 12(47): eaeg6837
      The perinatal heart undergoes a rapid metabolic transition from glycolysis to fatty acid oxidation that requires extensive mitochondrial remodeling, yet the molecular checkpoints that coordinate this process remain poorly defined. Using temporally resolved proteomics and complexome profiling of developing mouse hearts from late gestation through early postnatal life (E18.5 to P10), we identify a discrete developmental window in which respiratory chain architecture is remodeled to enable metabolic commitment. Complex IV (CIV) emerges as a central structural determinant of this transition, undergoing isoform-specific reassembly and transient suppression at birth before incorporation into mature respiratory supercomplexes. We identify the CIV subunit COX7C as a developmentally regulated determinant of CIV maturation, with its abundance increasing during maximal respirasome assembly and the switch to fatty acid oxidation. Loss of COX7C impairs terminal CIV maturation, prevents incorporation of heart-specific isoforms, and destabilizes the respirasome organization. Notably, this defect causes a selective secondary failure of complex I completion, demonstrating that respirasome formation is required for catalytic CI maturation in vivo. Consequently, cardiac-specific COX7C deficiency fails to complete the perinatal metabolic transition, leading to the collapse of fatty acid oxidation, activation of nucleotide and serine-glycine-one-carbon metabolism, attenuated activation of the mitochondrial integrated stress response, and a metabolically and structurally compromised state unlikely to support the increasing energetic demands of the postnatal heart. Together, these findings define a developmentally timed, CIV-dependent assembly step that couples respiratory chain assembly to postnatal cardiac metabolic fate and provide a temporal framework for mitochondrial maturation in the developing heart.
    DOI:  https://doi.org/10.1126/sciadv.aeg6837
  3. Sci Adv. 2026 Nov 20. 12(47): eaeg4754
      Mitochondrial homeostasis is maintained by molecular chaperones and proteases located within the organelle. The mitochondrial matrix-localized protease LONP-1 degrades oxidatively damaged or misfolded proteins. Importantly, LONP-1 also regulates mitochondrial DNA replication. Here, we show that mutations in C. elegans that impair LONP-1 function cause dysregulation of mitochondrial DNA replication, mitochondrial RNA transcription and protein synthesis within the mitochondrial matrix. LONP-1 deficient worms had reduced levels of oxidative phosphorylation proteins despite increased mtDNA-encoded protein synthesis. Via a forward genetic screen, we identified three mutations that restored mitochondrial function and the rate of development in lonp-1 mutants to levels comparable to those in wildtype worms. Interestingly, all three suppressor mutations were found in genes encoding mitochondrial ribosome proteins. A point mutation in the mitochondrial ribosome protein MRPS-38 restored oxidative phosphorylation in lonp-1 mutant worms. Combined, our results suggest that LONP-1 regulates mitochondrial translation and that suppressor mutations within mrps-38 or mrps-15 can enhance oxidative phosphorylation complex assembly when LONP-1 function is diminished.
    DOI:  https://doi.org/10.1126/sciadv.aeg4754
  4. Front Cell Dev Biol. 2026 ;14 2010196
      Genetic perturbation in the inner mitochondrial membrane protein MPV17 causes hepatocerebral mitochondrial DNA (mtDNA) depletion syndrome with nonfunctional mitochondrial respiratory chain biogenesis in humans. However, existing disease models fail to establish MPV17's molecular role and to recapitulate the neurological deficits. To overcome this limitation and elucidate the underlying disease mechanism, we utilized yeast Saccharomyces cerevisiae and Caenorhabditis elegans worm models alongside compound screening that restores respiratory defects of MPV17 deletion. Our study uncovered that the yeast ortholog, Stress-induced MPV17 (SYM1), knockout S. cerevisiae cells have ~50% reduced total iron and significantly downregulated Fe-S-containing respiratory enzyme activities under the higher 37 °C temperature stress. Moreover, supplementation with ferrous ammonium sulfate (FAS), which increases cellular iron levels, restores the respiratory growth of SYM1-deleted S. cerevisiae cells. Similarly, we found that loss of mpv-17 in C. elegans reduced iron levels, diminished mitochondrial respiratory activity, and caused severe developmental and locomotor defects, including impaired egg laying, omega turns, body bends, and thrashing behaviors. Remarkably, FAS supplementation significantly rescued these locomotor defects in vivo, demonstrating that restricted iron availability is the primary driver of cellular dysfunction in mpv-17-deleted C. elegans. Using purified human MPV17 protein, we further show that MPV17 binds exclusively to Fe2+ ions. Furthermore, silencing of MPV17 in human liver HepG2 cells showed changes in mitochondrial morphology and reduction in ATP synthesis. Because proper neuronal development relies on robust mitochondrial respiration and iron-dependent metabolism, these findings together establish a direct causal link between mitochondrial MPV17 and iron regulation and neurological development.
    Keywords:  C. elegans; HepG2; MPV17; SYM1; Saccharomyces cerevisiae; iron
    DOI:  https://doi.org/10.3389/fcell.2026.2010196
  5. Ther Adv Rare Dis. 2026 Jan-Dec;7:7 26330040261491754
      We describe a 27-year-old female of mixed European ancestry with rare/novel variants in MPV17 confirmed on whole exome sequencing with a multisystemic, predominantly neuropathic phenotype. She presented at birth with growth faltering, but was otherwise well. At the age of 9 years, she presented with persistent mild elevation in liver transaminases, hypoglycemia, and unilateral ptosis following a gastroenteritis episode. At 16 years, her growth had improved, but she developed a rapidly progressive sensory and motor axonal neuropathy with distal weakness and muscle atrophy, bilateral sensorineural hearing loss, liver nodules, hypothyroidism and primary amenorrhea. She also reported onset of unilateral fatigable ptosis several years prior. Trio whole exome sequencing (GeneDx) revealed compound heterozygous likely pathogenic variants in MPV17 (NM_002437.4), c.191C>T; p. Pro64Leu and c.375+5G>T. Diagnostic muscle biopsy performed at age 16.8 years revealed proliferated mitochondrial (mt)DNA content of 149% of the control mean value in skeletal muscle tissue, while liver biopsy at age 18.6 years demonstrated mtDNA depletion, at 15% of the control mean value. Although classic MPV17- mtDNA depletion syndromes (MDS) are typically associated with early mortality secondary to liver failure, this patient presented in adolescence with multisystem disease with a predominant peripheral neuropathy phenotype and non-progressive, mild liver involvement with preserved synthetic function. Eleven years following her initial presentation, her clinical picture remains predominantly neuropathic, with only mild liver involvement.
    Keywords:  Hepatocerebral; MPV17, peripheral neuropathy; mitochondrial DNA depletion syndrome (MDS)
    DOI:  https://doi.org/10.1177/26330040261491754
  6. Cell Rep. 2026 Nov 16. pii: S2211-1247(26)01386-0. [Epub ahead of print] 118307
      Mitochondrial β-barrel proteins fulfill essential functions for cell viability, including transport of proteins, ions, and metabolites, across the outer membrane. The translocase of the outer membrane (TOM complex) and the sorting and assembly machinery (SAM complex) transport these proteins into the outer membrane. Although β-barrel proteins are essential for cell viability, the quality control mechanisms that monitor their import into the outer membrane remain unknown. We uncovered that Msp1 and Ubx2-recruited Cdc48 cooperate to remove translocation-impaired β-barrel proteins from mitochondria. Non-imported β-barrel proteins are deposited in cytosolic protein storages, termed MitoStores, to minimize accumulation of aberrant proteins in the cell. The cytosolic AAA-ATPase Hsp104 disaggregates these proteins to facilitate their proteasomal degradation. Altogether, mitochondrial and cytosolic factors cooperate to degrade translocation-arrested mitochondrial β-barrel proteins.
    Keywords:  CP: metabolism; CP: molecular biology; MitoStores; SAM complex; TOM complex; mitoTAD; mitochondria; outer membrane; protein degradation; protein translocase
    DOI:  https://doi.org/10.1016/j.celrep.2026.118307
  7. Methods Mol Biol. 2027 ;3104 219-235
      Several animal models are used to discover novel treatments for the symptoms of Parkinson's disease (PD). PD models can be divided into two models: neurotoxin models and genetic models. Among neurotoxins to produce PD models, 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and rotenone, which inhibit the mitochondrial complex I, are widely used. Animal models of PD using these neurotoxins are also known as mitochondrial toxin models. Here, this chapter describes the preparation of these mitochondrial toxin models.
    Keywords:  1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); 6-hydroxydopamine (6-OHDA); Mitochondrial complex I; Mouse; Rat; Rotenone
    DOI:  https://doi.org/10.1007/978-1-0716-5699-0_20
  8. Nat Commun. 2026 Nov 20. pii: 11877. [Epub ahead of print]17(1):
      Given the large size of neurons, local maintenance of mitochondria is crucial to counteract insults to this organelle in axons and dendrites. The Parkinson-related mitochondrial kinase PINK1 plays a central role in mitochondrial quality control, which in neurons requires the transport of Pink1 mRNA by mitochondrial hitch-hiking. However, how and where PINK1 is locally translated and processed has remained unclear. Using live-cell imaging, we trace local PINK1 translation sites and preprotein dynamics, revealing a concerted interplay between mitochondria and the ER, with endolysosomes frequently localized adjacent to the site of translation. Upon metabolically regulated untethering from mitochondria, Pink1 mRNA relocates to ribosomes in proximity to the ER and endolysosomes for translation of the PINK1 preprotein. The ER chaperone DNAJB6 shields the PINK1 preprotein in transit to mitochondria, following the post-translational ER-SURF pathway. Consequently, loss of DNAJB6 leads to persistent ER/endolysosome-associated PINK1 precursor stores and failure of mitophagy upon mitochondrial damage. Our findings reveal that neuronal PINK1 protein translation switches between mitochondrially anchored co-translational and ER-associated post-translational import states, with functional implications for mitochondrial quality control.
    DOI:  https://doi.org/10.1038/s41467-026-79754-5
  9. Genome Biol. 2026 Aug 27. pii: 366. [Epub ahead of print]27(1):
       BACKGROUND: Mitochondrial DNA (mtDNA) mutations cause multisystem disorders often involving gastrointestinal dysfunction. However, the mechanisms governing the selection against mutant mtDNA and the specific impact of pathogenic mtDNA mutations on intestinal epithelial cells (IECs) remain poorly understood. Here, we employed mitochondrial single-cell assay for transposase-accessible chromatin with sequencing (mtscATAC-seq) to profile heteroplasmy dynamics in nine subtypes of IECs in m.G5081A (mt-tRNA) and m.G12918A (mt-mRNA) mutant mouse models over a two-year lifespan.
    RESULTS: Our findings reveal an age-dependent decline in mtDNA mutation in all IECs, a process originating within the intestinal stem cell compartment. Integrating single-cell RNA sequencing data, we observe that young mice harboring high m.G5081A mutation loads exhibit profound IEC dysfunction, characterized by impaired enterocyte differentiation and defective Paneth cell granule formation. Furthermore, m.G5081A mice display increased susceptibility to dextran sulfate sodium induced acute colitis, attributed to impaired intestinal barrier restoration driven by mitochondrial dysfunction.
    CONCLUSIONS: Collectively, our study elucidates the heteroplasmy dynamics of mtDNA mutations in IECs during aging and demonstrates the functional consequences of mitochondrial defects on intestinal health, offering critical insights into the pathogenesis and potential management of mitochondrial diseases.
    Keywords:  Colitis; Intestine; Mitochondria; Selection; Single-cells
    DOI:  https://doi.org/10.1186/s13059-026-04256-y
  10. J Cell Biol. 2026 Dec 07. pii: e202610012. [Epub ahead of print]225(12):
      In this issue, Wang et al. (https://doi.org/10.1083/jcb.202511010) show that adult Drosophila horizontal system dendrites remain structurally and functionally intact despite mitochondrial depletion, contrasting with the necessity of mitochondria during development. Their findings suggest that visual system functionality does not require mitochondrial functions under ideal conditions.
    DOI:  https://doi.org/10.1083/jcb.202610012
  11. EMBO Mol Med. 2026 Nov 17.
      Mitochondria and lysosomes are central regulators of cellular metabolism, nutrient sensing, cellular quality control, and stress adaptation. Although traditionally studied as independent organelles, it is now evident that they operate as an integrated functional network through multiple modes of communication, including membrane contact sites, signaling pathways, and selective vesicular trafficking. Disruption of this crosstalk is increasingly recognized as a common feature of mitochondrial disorders, lysosomal storage diseases, neurodegeneration, cardiovascular disease, and aging, highlighting its importance for cellular and tissue homeostasis. While mitophagy has long been considered the principal interface between mitochondria and lysosomes, recent discoveries have revealed a much broader communication landscape in which bidirectional signaling, ion exchange, lipid transfer, and mitochondria-derived vesicles coordinate organelle function independently of bulk degradation. In this Review, we discuss the molecular mechanisms that mediate mitochondria-lysosome communication, emphasizing emerging concepts in inter-organelle signaling and membrane contact biology. We further examine how disruption of these pathways contributes to human disease and consider the growing evidence that restoring mitochondria-lysosome communication, rather than targeting either organelle in isolation, represents a promising therapeutic strategy.
    DOI:  https://doi.org/10.1038/s44321-026-00556-9
  12. Methods Cell Biol. 2026 ;pii: S0091-679X(26)00188-3. [Epub ahead of print]211 1-24
      The BCL-2 family comprises pro- and anti-apoptotic proteins that integrate cellular stress signals to regulate mitochondrial apoptosis, with BAX serving as the central executioner that determines commitment to cell death. BAX activation proceeds through a continuum of events including conformational rearrangement of cytosolic BAX, mitochondrial translocation and insertion, and assembly into higher-order oligomers that induce mitochondrial outer membrane permeabilization (MOMP). This chapter presents complementary biochemical methods to monitor each step: (i) resolution of BAX monomer/dimer/oligomer species by blue-native PAGE (BN-PAGE) or size-exclusion chromatography (SEC) of cytosolic and mitochondrial fractions and immunoblotting; (ii) detection of early activation using conformation-specific 6A7 immunoprecipitation; (iii) quantification of mitochondrial translocation by subcellular fractionation and immunoblotting; and (iv) functional assessment of MOMP by immunoblot detection of cytochrome c release and decrease of mitochondrial membrane potential using potentiometric dyes. These protocols provide a comprehensive toolkit for investigating BAX activation mechanisms in mammalian cells.
    Keywords:  Apoptosis; BAX; BCL-2 family; Blue native PAGE; Cytochrome c release; Immunoblotting; Immunoprecipitation; Membrane potential; Mitochondria; Mitochondrial outer membrane permeabilization (MOMP); Mitochondrial translocation; Oligomerization; Size-exclusion chromatography; Subcellular fractionation
    DOI:  https://doi.org/10.1016/bs.mcb.2026.05.020
  13. Biochim Biophys Acta Mol Cell Res. 2026 Nov 19. pii: S0167-4889(26)00145-X. [Epub ahead of print] 120246
      The human mitochondrial genome (mtDNA) encodes a set of tRNAs (mt-tRNAs) that are central to the synthesis of oxidative phosphorylation (OXPHOS) complexes. To become functional, mt-tRNAs undergo a multi-step maturation process that involves their release from polycistronic transcripts by sequential 5' and 3' processing and the introduction of a variety of post-transcriptional modifications. In animals, the mutational erosion of mt-RNAs, driven by strong mutation pressure and random drift, has led to both a unique molecular maturation machinery and a strong association with human pathologies. Here, we review recent structural and functional insights into the core mitochondrial tRNA maturation pathway, from 5' cleavage by mitochondrial RNase P to 3' processing by RNase Z and finally the non-templated addition of the universal 3'CCA end by the CCA-adding enzyme. We discuss the molecular strategies underlying the recognition, catalysis, and quality control of each maturation step, the role of the TRMT10C-SDR5C1 complex as a universal mitochondrial tRNA maturation platform and its implications for the evolutionary history and disease association of human mitochondrial tRNA maturation.
    Keywords:  Cryo-EM; Mitochondria; Mitochondrial disease; RNA processing; tRNA
    DOI:  https://doi.org/10.1016/j.bbamcr.2026.120246
  14. Mol Neurobiol. 2026 Nov 19. pii: 1048. [Epub ahead of print]63(1):
      Mitochondrial dysfunction is a defining feature of Parkinson's disease (PD), but it is still often framed as a neuron-autonomous defect of vulnerable dopaminergic neurons. This view misses an intercellular layer of mitochondrial quality control in which glia, extracellular vesicles, tunnelling nanotubes, and mitochondrial extrusion pathways influence whether mitochondrial material is retained, degraded, transferred, or released. In acute CNS injury, mitochondrial transfer can restore bioenergetic capacity in stressed cells. In PD, the same process is unlikely to be uniformly protective. PINK1/Parkin, LRRK2, GBA1, and α-synuclein affect mitochondrial quality control, organelle trafficking, vesicle biology, lysosomal clearance, and innate immune activation. These changes create conditions in which transferred cargo may be beneficial, disposable, or harmful. Here, we distinguish direct PD evidence from mechanisms inferred from other CNS disorders and general cell biology. We interpret mitochondrial transfer in PD through two linked variables: cargo quality and recipient cell state. Functional mitochondria may support metabolic repair; damaged organelles may be routed for disposal; and α-synuclein- or mtDNA-associated cargo may propagate proteopathic stress and inflammation. Therapeutic strategies should therefore focus less on increasing mitochondrial movement per se than on enriching competent cargo, preserving donor cell fitness, and preventing transfer routes from amplifying pathology.
    Keywords:  Extracellular vesicles; Mitochondrial quality control; Mitochondrial transfer; Mitophagy; Neuroinflammation; Parkinson’s disease; Tunnelling nanotubes; α-Synuclein
    DOI:  https://doi.org/10.1007/s12035-026-06355-0
  15. Nat Commun. 2026 Oct 23. pii: 11867. [Epub ahead of print]17(1):
      Gametogenesis rejuvenates the cellular lineage and excludes senescence-associated factors from gametes. In Saccharomyces cerevisiae, this involves sequestration of nuclear constituents into the Gametogenesis Uninherited Nuclear Compartment (GUNC), which is excluded from gametes. Here we identify the conserved mitochondrial import receptor Tom70 as a key regulator of GUNC-mediated exclusion. Loss of TOM70 disrupts the sequestration of nuclear pore complexes, but not senescence-associated aggregates and nucleolar components, into the GUNC. Tom70's role appears independent of its canonical function in mitochondrial import and instead reflects a meiosis-specific requirement for mitochondria-nuclear envelope tethering. During meiosis II, Tom70 concentrates around the GUNC, where it recruits the nuclear envelope tethering protein Cnm1. Loss of CNM1 partially phenocopies tom70∆, consistent with parallel tethering interactions. These findings uncover a previously unrecognized organelle contact-dependent pathway that remodels the nuclear envelope to support selective nuclear inheritance. More broadly, they highlight how organelle contacts integrate with nuclear quality control to safeguard gamete integrity.
    DOI:  https://doi.org/10.1038/s41467-026-78562-1
  16. Methods Mol Biol. 2027 ;3104 169-180
      The physiological importance of mitochondrial quality control has been uncovered by the finding that genes for early-onset Parkinson's disease (PD), PINK1 and Parkin, regulate mitochondrial autophagy, called mitophagy, and motility. Dopaminergic neurons derived from human induced pluripotent stem (iPS) cells are a useful tool for analyzing the pathogenesis caused by defects in mitochondrial quality control and for screening candidate drugs for PD. Moreover, dopaminergic neurons could provide new findings not obtained in other cells. In this chapter, we will describe our method for monitoring PINK1-Parkin signaling using iPS cell-derived dopaminergic neurons.
    Keywords:  Autophagy; Dopaminergic neuron; Immunocytochemistry; Mitochondria; PINK1; Parkin; Ubiquitin; Western blot; iPS cells
    DOI:  https://doi.org/10.1007/978-1-0716-5699-0_16
  17. Biochemistry. 2026 Nov 17. 65(22): 3621-3637
      G-quadruplexes (G4) are stable secondary structures that can impede DNA replication, transcription, and translation. Although the human mitochondrial helicase Suv3 (SUPV3L1) is essential for RNA unwinding in mitochondrial RNA decay pathways, its involvement in resolving G4-RNA remains poorly characterized. Here, we demonstrate that dimeric Suv3 binds G4-RNA with nanomolar affinity, independently of ATP and irrespective of a 3' overhang. However, efficient catalytic resolution of G4-RNA by Suv3 requires both ATP hydrolysis and a minimum 3' single-stranded overhang of approximately 12 nucleotides to serve as a loading dock. Our findings support a translocation-based mechanism whereby efficient G4 resolution is initiated by the binding of Suv3 to G4-RNA with a long 3' overhang, and this interaction triggers ATP hydrolysis, subsequent enzyme translocation, and G4 unfolding. We further show that dimeric Suv3 is markedly more effective than its monomeric counterpart in resolving G4-RNA, particularly under physiologically relevant mitochondrial salt conditions. Structural modeling supports that dimeric Suv3 functions as an asymmetric complex, with one of the subunits together with the C-terminal tails interacting with the G4 core structure, while the other subunit tethers the long 3' overhang to enhance enzymatic efficiency and processivity. Together, these results establish Suv3 as a mitochondrial G4-RNA resolvase and provide a mechanistic framework for understanding how Suv3 dysfunction is linked to aberrant RNA processing in mitochondria and disease.
    DOI:  https://doi.org/10.1021/acs.biochem.6c00544
  18. Aging (Albany NY). 2026 Nov 13. 18(1): 1553-1563
      Mitochondrial DNA mutations can contribute to respiratory dysfunction and aging phenotypes, but they have not been established as the universal initiating cause of human aging. This Perspective compares mitochondrial transplantation with a proposed gene therapy strategy without presuming therapeutic superiority. Transplantation supplies functional organelles and has encouraging evidence in selected models and small clinical studies of acute injury. Gene transfer could support sustained endogenous mitochondrial maintenance, although that advantage remains untested for systemic aging. Four candidate mechanisms are considered: TERT associated mitochondrial protection, TFEB mediated lysosomal quality control, POLG and TFAM dependent genome maintenance with selective respiratory subunit supplementation, and FGF21 mediated metabolic signaling. Their evidence ranges from cellular mechanisms and animal studies to clinical experience in distinct disease indications. Important limitations include tumor promotion, inappropriate autophagy or genome packaging, endocrine adverse effects, vector toxicity, and uncertain coordination of multiple transgenes. A staged comparison should measure tissue specific target engagement, pathogenic heteroplasmy, respiratory function, organ performance, and long-term safety. Neither approach has demonstrated systemic human age reversal. The proposed framework is a falsifiable research agenda, with potential complementarity between organelle replacement and endogenous maintenance.
    Keywords:  aging; gene therapy; mitochondrial DNA; mitochondrial quality control; mitochondrial transplantation
    DOI:  https://doi.org/10.18632/aging.206440
  19. bioRxiv. 2026 Nov 12. pii: 2026.11.10.765195. [Epub ahead of print]
      Müller glia regenerate retinal neurons after injury in zebrafish, but how their mitochondrial organization changes during regenerative activation remains poorly defined. Here, we combined mitochondrial imaging, Müller glial transcriptomics, and whole eyecup metabolomics to investigate the response to selective photoreceptor loss. A Müller glia mitochondrial reporter revealed spatial and temporal mitochondrial remodeling: morphological changes were detectable in inner retinal compartments before sustained increases in mitochondrial volume emerged in processes adjacent to injured photoreceptors. This response coincided with reduced respiratory chain transcript expression and selective induction of mitochondrial assembly and maintenance genes, while the eyecup underwent temporally patterned metabolic changes. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinases (PDK), attenuated outer-retinal Müller glial mitochondrial remodeling. DCA also reshaped the Müller glial transcriptional response to injury, suppressing reprogramming- and cell-cycle-associated programs and altering metabolic and mitochondrial gene expression. DCA treatment also blocked the formation of tuba1a :GFP + Müller glia and PCNA expression, indicating that reprogramming and progenitor proliferation requires PDK activity. Together, our findings identify compartment-specific mitochondrial remodeling as an early event in the Müller glial regenerative response and demonstrate that mitochondrial remodeling and regenerative activation are sensitive to perturbation of the PDK-PDH regulatory axis.
    Significance Statement: Zebrafish Müller glia can generate progenitors that replace injured retinal neurons, but how their mitochondria reorganize during this transition remains poorly understood. We show that localized photoreceptor loss elicits mitochondrial remodeling across Müller glial compartments, with distinct temporal responses that accompany selective mitochondrial gene regulation and tissue-level metabolic changes. Inhibiting pyruvate dehydrogenase kinases attenuates outer-retinal mitochondrial remodeling and markedly reduces reprogramming-associated and proliferative responses. These findings identify spatial mitochondrial organization as a component of regenerative glial activation and establish a framework for investigating how metabolic regulation influences endogenous retinal repair.
    DOI:  https://doi.org/10.64898/2026.11.10.765195
  20. Cell Rep. 2026 Nov 17. pii: S2211-1247(26)01436-1. [Epub ahead of print] 118357
      β-barrel proteins are critical gatekeepers of the outer mitochondrial membrane, yet the mechanisms underpinning their quality control are largely unexplored. Here, Kämmerer et al.1 identify three AAA-ATPases that extract and facilitate the degradation of translocation-arrested β-barrel proteins.
    DOI:  https://doi.org/10.1016/j.celrep.2026.118357
  21. HeartRhythm Case Rep. 2026 Nov;12(11): 1483-1488
      
    Keywords:  Cardiomyopathy; Genetic disease; Long QT; Mitochondrial disease; Sudden cardiac death; Ventricular tachycardia
    DOI:  https://doi.org/10.1016/j.hrcr.2026.07.033
  22. Methods Mol Biol. 2027 ;3104 377-384
      The ATP-producing organelle, mitochondrion, controls cellular or synaptic Ca2+ concentrations through temporal uptake of Ca2+ outside of the mitochondria. Although intracellular Ca2+ influx occurs during neuronal activity, a persistently higher concentration of intracellular Ca2+ is neurotoxic. Healthy mitochondria ensure rapid Ca2+ uptake, which is necessary for proper neuronal activity. Mitochondrial Ca2+ buffering activity decreases in aged or sick neurons. In this chapter, we will introduce our protocol for evaluating Ca2+ buffering activity through the mitochondria during neuronal activity of dopaminergic neurons.
    Keywords:  Ca2+ buffering; Dopaminergic neuron; Drosophila; GCaMP; Live imaging; Mitochondria; Synaptic activity
    DOI:  https://doi.org/10.1007/978-1-0716-5699-0_33
  23. Diabetes. 2026 Nov 19. pii: db260508. [Epub ahead of print]
      Mitochondrial fission, mediated in part by dynamin-related protein 1 (DRP1), is a critical modulator of mitochondrial quality control and skeletal muscle function. We investigated the effects of reduced DRP1 action in muscle cells on mitochondrial morphology and local and systemic metabolism in adult mice. DRP1 downregulation in vitro resulted in elongated mitochondria, decreased mitochondria and endoplasmic reticulum contacts, and induced stress-response pathways. In contrast, selective DRP1 deletion in adult skeletal muscle using a tamoxifen-inducible Cre-loxP system (knockout [KO]) did not alter mitochondrial morphology or respiratory capacity. Nonetheless, KO mice exhibited markedly reduced age- and diet-dependent weight gain and adiposity, in concert with increased energy expenditure, compared with littermate controls. KO mice had enhanced insulin sensitivity, suppressed hepatic glucose production, and elevated glucose uptake in skeletal muscle and thermogenic adipose tissue. Mechanistically, transcriptomic profiling identified induction of activating transcription factor 4, and its downstream targets, fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) in skeletal muscle, which correlated with elevated circulating levels. In conclusion, DRP1 downregulation in adult skeletal muscle prevents obesity, increases insulin sensitivity, and improves glucose disposal, likely via activation of adaptive stress pathways and induction of FGF21 and GDF15 as myokines in the absence of changes in mitochondrial morphology or bioenergetics.
    ARTICLE HIGHLIGHTS: Reduced mitochondrial fission has been implicated in metabolic regulation, but the role of DRP1 in adult skeletal muscle metabolism remains incompletely understood. We investigated whether skeletal muscle-specific DRP1 deficiency in adult mice alters mitochondrial morphology and function and influences whole-body energy and glucose metabolism. Adult skeletal muscle DRP1 deficiency prevented age- and diet-induced obesity, increased energy expenditure, improved insulin sensitivity and glucose disposal, and induced ATF4-dependent stress responses with increased FGF21 and GDF15 production despite preserved mitochondrial morphology and respiratory capacity. These findings identify DRP1 as a regulator of systemic metabolic homeostasis and suggest that muscle stress signaling can improve metabolic health independently of changes in mitochondrial morphology.
    DOI:  https://doi.org/10.2337/db26-0508
  24. J Am Chem Soc. 2026 Nov 18. 148(45): 48924-48935
      Metal-Organic Frameworks (MOFs) are emerging as versatile materials for bio-interfaces due to their structural tunability and ability to integrate with biological systems. Among them, the Zeolitic Imidazolate Framework ZIF-8 is widely investigated as a carrier for the delivery of therapeutic agents owing to its chemical stability, porous architecture, and biocompatibility. Extending these strategies to complex biological substrates is particularly relevant for therapeutic applications. In this context, mitochondria represent key targets, as they regulate cellular metabolism and their dysfunction underlies numerous mitochondrial diseases, thereby stimulating growing interest in mitochondrial transplantation as a potential therapeutic approach. Here, we investigate the one-pot, in-situ formation of ZIF-8 coatings on isolated mitochondria under physiological conditions using mild micromolar precursor concentrations to minimize mitochondrial perturbation during the self-assembly process. Structural characterization and bioenergetic analyses confirm the formation of MITO@ZIF-8 and the preservation of mitochondrial respiratory competence. Transplantation of MITO@ZIF-8 into Mouse Embryonic Fibroblasts (MEFs) increases cellular respiratory capacity without affecting cell viability, indicating that the coating is biocompatible and does not impair mitochondrial uptake. These results provide a safe platform for the further engineering of delivery systems aimed at enhancing internalization efficiency in mitochondrial transplantation therapeutics.
    DOI:  https://doi.org/10.1021/jacs.6c11154
  25. Contact (Thousand Oaks). 2026 Jan-Dec;9:9 25152564261496636
      Mitochondria, endoplasmic reticulum and lipid droplet (Mito-ER-LD) tri-organelle membrane contact sites (MCS) have emerged as critical metabolic signalling platforms that coordinate fatty acid flux, phospholipid biosynthesis and energy homeostasis across three membrane bound compartments. Since the identification of mitoguardin-2 (MIGA2) as the first dedicated tri-organelle tether in 2019, the field has uncovered at least three distinct molecular complexes operating at these junctions, revealed functionally specialized mitochondrial subpopulations including peridroplet mitochondria (PDM) defined by their organelle interactions, and connected tri-organelle contact dysfunction to metabolic diseases including non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and neurodegeneration. Recent advances in mitochondrial 3D electron microscopy have revealed that mitochondrial structure including cristae architecture regulated by the MICOS complex is intimately linked to organelle contact site formation and metabolic function. Concurrently, multi-organelle imaging (OrgaPlexing), reversible biosensor design, and computational detection algorithms have transformed the field toward quantitative, dynamic analysis. Integrated multiscale microscopy approaches, from super-resolution to 3D Electron microscopy (3D EM) are now enabling comprehensive structure function mapping of these junctions. Here, we synthesize the current molecular, functional, and disease-related understanding of Mito-ER-LD contact sites, evaluate methodological breakthroughs, discuss evolutionary conservation of multi-organelle coordination, and identify critical open questions for the field.
    Keywords:  MIGA2; PLIN5; VAPB; endoplasmic reticulum; lipid droplet; membrane contact sites; mitochondria; peridroplet mitochondria
    DOI:  https://doi.org/10.1177/25152564261496636
  26. J Inherit Metab Dis. 2026 Nov;pii: e70274. [Epub ahead of print]49(6):
      Single large-scale mitochondrial DNA deletions (SLSMDs) give rise to a wide spectrum of clinical features, including Kearns-Sayre syndrome (KSS) and chronic progressive external ophthalmoplegia (CPEO). Because longitudinal data are scarce, the natural history remains poorly defined. This study was undertaken to describe the clinical spectrum in a large cohort of patients with clinical onset after 16 years of age. A retrospective multicenter study was performed in patients diagnosed and followed in seven European mitochondrial disease centers. Seventy patients were included. The median age at disease onset was 27 years, and the median age at last evaluation was 52 years, with a median follow-up duration of 19 years. Median survival from disease onset was 34 years. KSS spectrum disorder was present in 36% of the patients, while CPEO was identified in the remaining 64%. Among those with CPEO at onset, 27% progressed to KSS spectrum disorder. Multisystem involvement was present in 59%. The most frequently reported symptoms or signs were ptosis and/or ophthalmoplegia (100%), skeletal muscle weakness (56%), perceived fatigue (34%), visual impairment (30%), exercise intolerance (33%), pigmentary retinopathy (20%), hearing impairment (19%), cardiac conduction block (15%), ataxia (11%), epilepsy (14%), and cognitive impairment (11%). Our study gives further insight into the highly heterogenous clinical presentation and natural history associated with SLSMDs. The relevance of categorizing patients into classical syndromic phenotypes may be questioned, as the observed overlap in clinical manifestations and the frequent evolution of phenotype over time suggest a continuum of disease expression rather than clearly distinct syndromic entities.
    Keywords:  Kearns–Sayre syndrome; mitochondrial DNA; phenotype; progressive external ophthalmoplegia; sequence deletion
    DOI:  https://doi.org/10.1002/jimd.70274
  27. iScience. 2026 Nov 20. 29(11): 118138
      Mitochondrial dysfunction contributes to neuronal injury in Parkinson's disease, and astrocyte-derived mitochondria may offer neuroprotection by restoring neuronal bioenergetics. Here, we investigated the therapeutic potential of astrocyte-derived mitochondria in 6-OHDA models of Parkinson's disease. Using mitochondrial labeling and co-culture assays, we obtained evidence consistent with the release of astrocytic mitochondria, their uptake by injured neurons, and their association with the neuronal mitochondrial network. Building on this observation, we investigated whether direct delivery of functional astrocytic mitochondria could augment endogenous support during neuronal injury. Infused astrocytic mitochondria reduced oxidative stress, restored mitochondrial membrane potential, improved mitochondrial respiration, normalized calcium homeostasis, reduced early neuronal apoptosis, and restored mitochondrial mass. Astrocytic mitochondrial delivery enhanced dendritic arborization in primary neurons. In vivo, stereotactic infusion restored TH immunoreactivity in the SNpc and improved motor and non-motor behavioral deficits. These findings support the potential of astrocyte-derived mitochondria as a promising cell-free therapeutic approach for Parkinson's disease.
    Keywords:  6-OHDA; 6-hydroxydopamine; Parkinson’s disease; astrocytes; mitochondrial therapy; mitochondrial transfer; neurons; neuroprotection
    DOI:  https://doi.org/10.1016/j.isci.2026.118138
  28. Sci Adv. 2026 Nov 20. 12(47): eael2126
      Mitochondria transplantation is a proposed therapeutic approach to improve the function of diseased or injured tissue. It has garnered attention and sparked debate.
    DOI:  https://doi.org/10.1126/sciadv.ael2126
  29. Front Genet. 2026 ;17 1969094
      Leigh syndrome comprises genetically heterogeneous mitochondrial disorders, but interpretation of rare mitochondrial DNA variants is often limited by sparse longitudinal data. We report a male patient followed from childhood to age 16 with the MT-ND4 m.11470A>C (p. (Lys237Asn)) variant. Right-eye strabismus and optic atrophy appeared at age 3, followed by progressive limb weakness, gait instability, and dysarthria. At age 16, magnetic resonance imaging showed bilateral lesions involving the basal ganglia, thalami, midbrain, pons, and medulla oblongata. The patient subsequently developed respiratory failure requiring intubation and mechanical ventilation. The variant was detected in saliva at a pipeline-reported heteroplasmy level of 51.8% and was not detected by Sanger sequencing in saliva from the mother or dizygotic twin brother. APOGEE 2 predicted a potential deleterious effect, the affected residue was conserved, and static structural visualization suggested altered local contacts. A targeted review identified previous associations of m.11470A>C with MELAS and a Leigh syndrome record in a pediatric cohort. This detailed longitudinal case adds clinical and neuroimaging resolution to the reported m.11470A>C spectrum and supports integrating disease trajectory, tissue source, heteroplasmy, and family data when interpreting rare mitochondrial DNA variants.
    Keywords:  Leigh syndrome; MT-ND4; heteroplasmy; m.11470A>C; mitochondrial DNA; phenotype
    DOI:  https://doi.org/10.3389/fgene.2026.1969094
  30. Redox Biol. 2026 Nov 18. pii: S2213-2317(26)00490-8. [Epub ahead of print]98 104491
      Transfer RNAs (tRNAs) are increasingly recognized as dynamic regulators of gene expression rather than passive adaptors in protein synthesis. Yet their transcription, maturation, modification, aminoacylation, fragmentation, and noncanonical signaling have largely been examined separately. This review integrates these layers within the concept of the "tRNA regulome" and evaluates its bidirectional relationship with oxidative and mitochondrial stress. Reactive oxygen and nitrogen species alter metabolite and cofactor availability, and stress-responsive signaling remodels tRNA abundance, localization, chemical state, charging, and cleavage. These changes can restrain global translation while selectively supporting stress-responsive protein synthesis, alter decoding fidelity and ribosome behavior, intersect with mTOR and integrated stress response signaling, or generate regulatory tRNA-derived RNAs (tDRs). Mitochondria are central to this relationship: mitochondrial stress reshapes cytosolic translation, whereas defects in mitochondrial tRNAs or their processing, modification, and aminoacylation impair oxidative phosphorylation and, in selected models, perturb redox homeostasis. Human genetic disorders and experimental perturbations further show that cytosolic tRNA-regulome disruption can induce oxidative and mitochondrial dysfunction through mistranslation, ribosome stalling, and loss of proteostasis. Whether tRNA remodeling preserves homeostasis or amplifies injury depends on the perturbation and cellular context. This review also examines analytical limitations that obscure coordination among regulome layers and assesses emerging therapeutic and biomarker opportunities. Understanding the tRNA regulome as an integrated, compartment-spanning stress-response network should clarify how redox signals are translated into adaptive or pathological cell-fate decisions.
    Keywords:  Mitochondrial dysfunction; Oxidative stress; Translational regulation; tRNA; tRNA-derived RNAs
    DOI:  https://doi.org/10.1016/j.redox.2026.104491
  31. Nat Commun. 2026 Oct 21. pii: 11832. [Epub ahead of print]17(1):
      Protein synthesis depends on specialized regulatory factors to overcome difficult-to-translate sequences during elongation that cause ribosomal stalling. In human mitochondria, this function is carried out by TACO1 (Translation activator of COX1). Here, we report the cryo-electron microscopy structure of human TACO1 bound to the mitoribosome, revealing its mechanistic role as a dedicated elongation regulator. Unlike the prokaryotic elongation factor EF-P and the eukaryotic eIF5A, which bind the ribosomal E site and stabilize P-site tRNA to facilitate peptide bond formation, TACO1 adopts a distinct strategy. It binds near the A site, closely interacting with the Sarcin Ricin loop and the L7/L12 stalk, similar to general translation elongation factors, such as EF-Tumt and mtEF-G1mt, and contacts the A-site tRNA. Using AlphaFold analysis and molecular dynamics simulations, we further show how a series of conformational changes allow its N-terminal domain to reorient and transiently engage with the A-site tRNA via a conserved and functionally critical basic amino acid patch. The bacterial homolog of TACO1, namely YebC2, shares the structural features required for its function. Overall, we present an evolutionarily conserved mechanism employed by TACO1 to enhance mitochondrial translation efficiency.
    DOI:  https://doi.org/10.1038/s41467-026-78692-6
  32. Yi Chuan. 2026 Nov;48(11): 1066-1084
      Mitochondrial diseases are a group of highly heterogeneous genetic disorders that affect any organ at any age, caused by mutations in nuclear and mitochondrial genes, and characterized by complex clinical manifestations and diagnostic challenges. Multi-omics technologies have emerged as essential tools for deciphering the molecular basis of these diseases and improving clinical outcomes. In this review, we summarize the research progress of multi-omics approaches-including genomics, transcriptomics, proteomics, metabolomics, and single-cell sequencing-in resolving genetic and phenotypic heterogeneity and elucidating cell- and tissue-specific mechanisms of representative mitochondrial diseases. We aim to provide a reference and framework for the translation of multi-omics technologies from basic research to clinical application within the field of mitochondrial medicine.
    Keywords:  heterogeneous; mitochondrial DNA; mitochondrial diseases; multi-omics; single-cell sequencing
    DOI:  https://doi.org/10.16288/j.yczz.26-109
  33. bioRxiv. 2026 Nov 05. pii: 2026.11.04.764401. [Epub ahead of print]
      In human neurons, energy-demanding axonal and dendritic development requires sufficient mitochondrial distribution at distal locations, and the responsible mechanisms remain largely unknown. Here, we characterize rare de novo mutations in microtubule-associated serine/threonine kinase 1 (MAST1) in patients with multiple neurodevelopmental abnormalities, including microcephaly and thin corpus callosum. Experiments using induced pluripotent stem cell-derived telencephalic brain organoids and cortical neurons from patients and unaffected parents, as well as engineered lines demonstrate association of the MAST1 mutations with organoid growth deficits and impaired neurites. Mechanistically, the MAST1 mutations alter its interaction with mitochondria as well as mitochondrial trafficking and abundance, increasing the proportion of hyperactive mitochondria and reactive oxygen species accumulation. Exogenous wild-type MAST1 expression rescues neurite outgrowth in mutant neurons, as does prolonged treatment with creatine or N -acetyl-L-cysteine. This study identifies MAST1 as an important regulator of mitochondrial properties in human neurons and links microcephaly-associated MAST1 mutations to neuronal mitochondrial dysfunction, impaired neurites, and neuronal loss.
    DOI:  https://doi.org/10.64898/2026.11.04.764401
  34. Nucleic Acids Res. 2026 Nov 10. pii: gkag1176. [Epub ahead of print]54(21):
      Mitochondrial transfer RNAs (mt-tRNAs) harbor diverse types of posttranscriptional modifications. The enzyme responsible for N2-methylguanosine (m2G) formation at position 10 in mammalian mt-tRNAs remains unidentified, and the cellular function and biological significance of mitochondrial m2G10 remain poorly understood. Here, we find that a fraction of TRMT11 and TRMT112 is localized in mitochondria. Leveraging genetic, biochemical, and mass spectrometry approaches, we demonstrate that TRMT11 and TRMT112 jointly catalyze m2G10 biogenesis in mt-tRNAs. Critical residues in both proteins essential for complex formation and enzymatic activity are identified. The deletion of TRMT11 has little effect on cytoplasmic translation velocity and other tRNA modifications, with marginal suppression in decoding limited codons. Although mitochondrial m2G10 deficiency has little impact on the abundance, charging, and other modifications of mt-tRNAs, it causes a migration shift of multiple mt-tRNAs in native gels, indicating an altered mt-tRNA architecture. Consistently, the decoding efficiency of MT-ND3, MT-ND6, MT-CO1, MT-CO2, and MT-CO3 messenger RNAs (mRNAs) is significantly impaired, causing changes in mitochondrial structure and function. Trmt11 knockout mice show no defects in development, growth, or functions in the heart, muscle, and spermatogenesis. Collectively, our results establish that TRMT11-TRMT112 is the mitochondrial m2G10 methyltransferase and reveal the differential roles of m2G10 on cytoplasmic and mitochondrial translation.
    DOI:  https://doi.org/10.1093/nar/gkag1176
  35. bioRxiv. 2026 Nov 04. pii: 2026.11.03.763232. [Epub ahead of print]
    Undiagnosed Diseases Network
      DNM1L encodes dynamin-related protein 1 (DRP1), a key GTPase regulating mitochondrial and peroxisomal dynamics. Pathogenic DNM1L variants are associated with a broad spectrum of neurodevelopmental and neurodegenerative disorders, with phenotypic severity varying by affected protein domain. While variants in the GTPase domain are typically associated with milder phenotypes and middle-domain variants with severe developmental and epileptic encephalopathy, the functional impact of GTPase effector domain (GED) variants remains less defined. Here, we describe four individuals harboring a recurrent heterozygous GED deletion (L700del) presenting with movement disorders and lacking severe infantile encephalopathy, consistent with an intermediate clinical phenotype. Patient-derived fibroblasts exhibited tubular peroxisomes and enlarged mitochondria, while Drosophila models demonstrated that DNM1L L700del has intermediate functional effects that were more pronounced than those of a GTPase-domain variant A192E but less severe than those of the middle-domain variant G350R. Comparison with another GED variant, Y691C, further demonstrated variant-specific differences in severity within the GED. Metabolic stress assays showed that L700del fibroblasts exhibited impaired growth under galactose conditions, consistent with increased vulnerability under conditions dependent on mitochondrial oxidative metabolism. Bezafibrate, a PPAR agonist that promotes mitochondrial biogenesis, partially rescued this growth defect. Together, these findings support a functional allelic spectrum in DNM1L -associated disease in which protein domain contributes to, but does not completely determine, functional severity. L700del represents an intermediate-strength allele associated with a movement-disorder phenotype and a pharmacologically modifiable metabolic vulnerability.
    DOI:  https://doi.org/10.64898/2026.11.03.763232
  36. Free Radic Biol Med. 2026 Nov 20. pii: S0891-5849(26)01289-X. [Epub ahead of print]
      The 4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) converts 4-hydroxyphenylpyruvate into 4-hydroxymandelate (4-HMA), an intermediate in an alternative pathway for the generation of 4-hydroxybenzoate (4-HB), a precursor of the Coenzyme Q10 (CoQ10) headgroup. However, the pathogenic mechanism of HPDL-related encephalopathy and related phenotypes such as spastic paraplegia (SPG83) remains unclear. In this study, we generated an hpdl-/- zebrafish model using the CRISPR/Cas9 methodology. Larvae exhibited microphthalmia, impaired yolk absorption, and a transition from hypokinetic-like to epilepsy-like activity. For the first time in HPDL-related research, we performed extensive lipidomic profiling, revealing a depletion of di- and triglycerides and cholesterol esters alongside mitochondrial membrane instability, marked by decreased acylcarnitines and increased dilysocardiolipins and hydroxy-acylcarnitines, a signature suggestive of impaired β-oxidation and oxidative damage. Bypass and antioxidant therapies using 4-HMA, 4-HB, and the mitochondrial-targeted scavenger MitoTempo were evaluated for their rescue potential. While almost all of the tested drugs successfully rescued the reactive oxygen species production, brain cell death and the altered neuronal activity, we observed that the metabolic recovery occurred independently of the levels of CoQ10 and CoQ9, which remained depleted. Our findings offer support to the hypothesis that Hpdl deficiency causes disease primarily through mitochondrial redox imbalance and lipid metabolic failure, rather than a simple CoQ10 depletion. In spite of unchanged CoQ10 levels, rescue of oxidative stress, brain cell death, and neuronal hyperexcitability in mutant larvae by 4-HMA, 4-HB, and MitoTempo supports a cytoprotective role for these aromatic metabolites, identifies HPDL as a key regulator of mitochondrial homeostasis, and a promising target for aromatic antioxidant therapy.
    Keywords:  4-HMA; HPDL; SPG83; lipidomic; oxidative stress; zebrafish
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.11.037
  37. Mamm Genome. 2026 Nov 16. pii: 1. [Epub ahead of print]38(1):
      Taurine is one of the most abundant free amino acids in mammals and plays essential roles in cellular homeostasis, mitochondrial function, calcium regulation and neuronal survival. Taurine availability varies markedly across tissues, species and sexes, reflecting the balance between endogenous synthesis, dietary intake, transport and efflux. Although reduced taurine levels have been reported in some aging tissues, recent longitudinal studies indicate that circulating taurine does not decline universally with age, and its value as a biomarker of aging remains debated. Alterations in taurine or its transporter SLC6A6 have been described in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington's disease and retinal degenerations. Preclinical studies indicate that taurine supplementation mitigates excitotoxicity, stabilizes mitochondrial function, reduces neuroinflammation and supports myelination and synaptic balance. Despite this strong mechanistic rationale, clinical evidence remains limited and heterogeneous, underscoring the need for biomarker-guided trials and a clearer definition of optimal therapeutic windows. In this review, we summarize the general properties of taurine and its metabolic regulation. We examine taurine's neuroprotective properties across different neurodegenerative conditions and discuss future perspectives for targeting taurine metabolism as a promising but largely unexplored strategy for intervention in age-related neurodegenerative diseases.
    Keywords:  Aging; Metabolism; Neurodegenerative diseases; Neuroprotection; Taurine; deficiency
    DOI:  https://doi.org/10.1007/s00335-026-10292-7
  38. Free Radic Biol Med. 2026 Jan;pii: S0891-5849(25)01316-4. [Epub ahead of print]242 150-166
      Age-related macular degeneration involves the gradual degeneration of retinal pigment epithelium (RPE) cells. A better understanding of the molecular mechanism underlying RPE impairment is beneficial to the treatment of AMD. Here, we identify VDAC1 oligomerization as a critical initiator of RPE cell degeneration and death in AMD development. Using in vitro and in vivo models, we demonstrate that VDAC1 forms oligomers that promote mitochondrial membrane permeabilization and facilitates the leakage of mitochondrial DNA (mtDNA). Cytosolic mtDNA serves as a potent stimulator of cGAS-STING pathway. Strikingly, we find that STING activation promotes assembly of the PANoptosome complex, which integrates components of pyroptosis (NLRP3), apoptosis (Caspase-8), and necroptosis (RIPK3). Pharmacological inhibition of either VDAC1 oligomerization or STING activation preserves mitochondrial integrity, suppresses mtDNA release, inhibits PANoptosis, and restores RPE function. Blockade of the VDAC1-mtDNA-STING-PANoptosis axis alleviates RPE atrophy, retinal thinning, and AMD-like ocular pathologies in a sodium iodate-induced AMD mouse model. Going further, we show that O-GlcNAcylation of VDAC1 at threonine 165 (T165) promotes its oligomerization and accelerates disease progression. Mutation of T165 diminishes O-GlcNAc modification, reduces VDAC1 oligomer formation, and inhibits subsequent activation of cGAS-STING signaling and PANoptosis. Together, our findings uncover a mechanism by which VDAC1 oligomerization-mediated activation of PANoptosis during AMD. This work identifies VDAC1 oligomerization and its regulatory O-GlcNAcylation as promising targets for therapeutic intervention and provides mechanistic insights into how mitochondrial stress links innate immunity and inflammatory cell death in retinal degenerative disease.
    Keywords:  Age-related macular degeneration; O-GlcNAcylation; PANoptosis; STING; VDAC1 oligomerization
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2025.10.285
  39. Elife. 2026 Nov 18. pii: RP111391. [Epub ahead of print]15
      Telomere shortening is a hallmark of aging, yet telomere length (TL) varies considerably between individuals and is strongly influenced by inheritance. In mice, efficient mitochondrial function and low reactive oxygen species (ROS) production are essential for telomere elongation during early embryogenesis. As mitochondrial DNA (mtDNA) encodes several subunits of the electron transport chain, we investigated whether mtDNA variants influence TL using a transmitochondrial cybrid model. Platelet-derived mitochondria from human donors with varying TL were introduced into mtDNA-depleted cells. Donor blood TL inversely correlated with cybrid ROS levels, suggesting that specific mtDNA variants may support telomere maintenance by enhancing mitochondrial fitness. During cybrid formation, a transient oxidative stress phase precedes cellular adaptation. At this stage, mtDNA variants associated with reduced complex I (CI) activity triggered rapid telomere shortening, which was rescued by antioxidant and NAD+ precursor supplementation. Although these variants occur naturally in some individuals with long telomeres, our findings suggest that, under conditions of acute in vitro oxidative stress, CI activity is critical for preserving telomere integrity, potentially through the regulation of NAD+/NADH balance and PARP1 activity. Overall, our findings support a role for mtDNA variation in human TL regulation and highlight potential therapeutic opportunities involving mitochondrial replacement strategies.
    Keywords:  cell biology; complex I; human; mitochondrial genome; reactive oxygen species; telomere length inheritance; telomeres
    DOI:  https://doi.org/10.7554/eLife.111391
  40. Integr Biol (Camb). 2026 Jan 16. pii: zyag025. [Epub ahead of print]18
      Human spaceflight exposes astronauts to microgravity and space radiation, yet whether these stressors produce a common molecular response across tissues has remained unclear. To address this, we performed a cross-mission meta-analysis of 70 spaceflight-versus-ground-control transcriptomic comparisons spanning 21 tissues and 16 missions from the NASA Open Science Data Repository, stratified by cumulative radiation exposure. We found that mitochondrial dysfunction is a consistent transcriptional signature of spaceflight: oxidative phosphorylation was significantly downregulated in the vast majority of in-flight datasets with exposure ≥10.34 mGy, accompanied by coordinated suppression of mitochondrial and cytosolic translation and mitochondrial protein import. In-flight datasets also showed activation of HIF-1α target genes and broad innate and adaptive immune dysregulation, including upregulation of mitochondrial DNA- and RNA-sensing transcripts consistent with mtDAMP-driven inflammation. After return to Earth, HIF-associated and most immune responses resolved, whereas oxidative phosphorylation suppression persisted in high-exposure datasets, dissociating transient adaptive responses from a sustained mitochondrial lesion. Mitochondrial suppression scaled with cumulative exposure and was greater in older, male, and C57BL/6 mice. Together, these findings establish mitochondrial dysfunction as a consistent, exposure-dependent, and persistent transcriptional feature to spaceflight, identifying mitochondrial bioenergetics and protein homeostasis as priority countermeasure targets for long-duration lunar and Mars missions. Biological insight We identify mitochondrial dysfunction as a conserved molecular response to spaceflight, characterized by suppression of oxidative phosphorylation, altered mitochondrial and cytosolic translation, and disruption of mitochondrial protein homeostasis. Technological innovation: We developed an integrated transcriptomic framework that harmonizes independent spaceflight datasets across missions, tissues, and biological backgrounds while preserving dataset-specific experimental structure. Benefit of integration: Joint analysis of 70 comparisons spanning 21 tissues and 16 missions revealed exposure-dependent and persistent mitochondrial alterations that were not apparent from individual datasets, while distinguishing sustained oxidative phosphorylation suppression from more transient stress and immune responses. This integrative approach provides a systems-level framework for identifying conserved biological responses and prioritizing mitochondrial pathways as potential targets for spaceflight countermeasures.
    Keywords:  OXPHOS; astronaut health; innate immunity; mitochondrial stress; mitochondrial translation; space radiation; spaceflight biology
    DOI:  https://doi.org/10.1093/intbio/zyag025
  41. Adv Sci (Weinh). 2026 Nov 15. pii: e78786. [Epub ahead of print]
      The pathway responsible for mitochondrial [4Fe-4S] cluster assembly plays a crucial role in humans, as evidenced by numerous mitochondrial diseases linked to its dysfunction. GLRX5, FDX2, FDXR, ISCA1, ISCA2, and IBA57 are the proteins involved in the assembly of [4Fe-4S] clusters, but how they cooperate at the molecular level to accomplish this assembly remains unclear. Here, we provide a comprehensive investigation that elucidates the elusive molecular function of IBA57 in mitochondrial [4Fe-4S] cluster assembly. We found that the IBA57 subunit of the [2Fe-2S] IBA57-ISCA2 complex specifically recognizes [2Fe-2S] FDX2 in a transient manner. This interaction enables rapid electron transfer from NADPH to the [2Fe-2S]2+ cluster of the IBA57-ISCA2 complex via the FDXR/FDX2 system, reducing the cluster to [2Fe-2S]+. An NMR data-driven structural model of the transient complex between [2Fe-2S] FDX2 and [2Fe-2S] IBA57-ISCA2 reveals a 17 Å electron transfer pathway connecting the [2Fe-2S] cluster of FDX2 to that of IBA57-ISCA2. Kinetic data showed that [2Fe-2S]+ IBA57-ISCA2, reduced by the NADPH/FDXR/FDX2 system, acts catalytically as an efficient electron donor, promoting reduction of the [2Fe-2S] cluster in the ISCA1-ISCA2 complex. These results highlight the role of IBA57 as an activator of the electron transfer pathway required for the formation of mitochondrial [4Fe-4S] clusters.
    Keywords:  FDX2; IBA57; [4Fe‐4S] cluster biosynthesis; electron transfer; iron‐sulfur protein biogenesis; mitochondria; protein‐protein interaction
    DOI:  https://doi.org/10.1002/advs.78786
  42. Cell Commun Signal. 2026 Aug 19. pii: 629. [Epub ahead of print]24(1):
      Autophagy maintains cellular homeostasis by degrading and recycling intracellular components, while the selective clearance of damaged mitochondria, known as mitophagy, ensures mitochondrial quality control. Protein complexes orchestrate these processes, yet their dynamic regulation remains incompletely understood. Here, we integrate thermal proteome profiling with co-aggregation analysis to monitor protein thermal stability and complex assembly dynamics in response to two canonical inducers: Torin 1, which activates autophagy via mTOR inhibition, and CCCP, a mitochondrial uncoupler that triggers mitophagy. This endeavor provides a global view of the dynamic variations of known autophagy- and mitophagy-associated complexes, revealing their assembly state at various stages. Notably, we identify previously uncharacterized complexes containing the eukaryotic elongation factor 1 A1 (EEF1A1) that exhibit enhanced aggregation under both treatments. Functional analyses show that EEF1A1 depletion impairs autophagosome maturation and mitophagic degradation, while pulsed-SILAC demonstrates that EEF1A1 directly regulates the synthesis of core autophagy proteins. Together, these findings map the dynamic landscape of protein complex regulation during autophagy and mitophagy and uncover EEF1A1-mediated translational control as a previously unrecognized regulatory mechanism.
    Keywords:  Autophagy; EEF1A1; Mitophagy; Protein complex; Thermal proximity co-aggregation; Translation
    DOI:  https://doi.org/10.1186/s12964-026-03152-z
  43. bioRxiv. 2026 Nov 13. pii: 2026.11.11.765941. [Epub ahead of print]
      Neuropathic pain is common and debilitating among diabetics. The reactive glycolytic metabolite methylglyoxal (MGO) is strongly associated with painful diabetic neuropathy. MGO triggers pain through activation of the integrated stress response (ISR). The underlying molecular mechanisms are unclear. Here, we show that general control nonderepressible 2 (GCN2) kinase acts as a conserved sensor that bridges glycolytic and mitochondrial dysfunction to pain hypersensitivity. In human sensory neurons derived from dorsal root ganglion (DRG), MGO increased eIF2α phosphorylation and suppressed global translation. These effects were blocked upon inhibition of GCN2. Unbiased ribosome profiling of mouse DRG revealed that MGO triggered repression of mRNAs that encode components of the electron transport chain. Based on this observation, mitochondrial dysfunction was examined as a potential upstream trigger for GCN2 activation. MGO directly glycated mitochondrial complex I and increased the NADH/NAD + ratio. Correcting this redox imbalance via expression of a mitochondrial-targeted bacterial NADH oxidase (mitoLbNOX) prevented ISR activation by MGO. In a streptozotocin-induced mouse model of diabetic neuropathy, pharmacological GCN2 inhibition or sensory neuron-specific conditional deletion significantly attenuated mechanical allodynia. Calcium imaging revealed that genetic deletion of GCN2 reduced calcium influx in response to an agonist of TRPA1. Finally, expression of mitoLbNOX using adeno-associated viruses (AAV) in DRG sensory neurons in vivo reduced streptozotocin-induced mechanical hypersensitivity. Our findings demonstrate that GCN2 is a central, conserved driver of translational dysregulation downstream of mitochondrial redox stress in diabetic pain. This work highlights the critical role of mitochondrial function and translational control as key drivers of painful diabetic neuropathy.
    DOI:  https://doi.org/10.64898/2026.11.11.765941
  44. Annu Rev Physiol. 2026 Nov 16.
      Mitochondria are central hubs of intracellular Ca2+ signaling, sensing, integrating, and responding to cytosolic Ca2+ transients through tightly regulated uptake and efflux pathways. Despite its fundamental role in cellular physiology, the mechanisms by which mitochondrial Ca2+ signaling contributes to tissue-specific pathologies remain poorly understood. Disruption of this ancient and ubiquitous process can lead to various disease phenotypes, including neurological disorders, stroke, heart failure, diabetes, and liver disease. This review highlights how extensive heterogeneity in the molecular composition, regulation, and spatial organization of mitochondrial Ca2+ signaling machinery underlies these pleiotropic outcomes. Physiological insights are examined alongside systems-level approaches, such as comparative genomics, evolutionary analyses, and protein-protein interaction mapping, to reveal context-specific architectures of mitochondrial Ca2+ signaling. Collectively, these advances provide a framework for understanding how mitochondrial Ca2+ uptake and efflux pathways are tailored to organ-specific functions and vulnerabilities.
    DOI:  https://doi.org/10.1146/annurev-physiol-040425-103836
  45. Biomaterials. 2026 Nov 13. pii: S0142-9612(26)00798-2. [Epub ahead of print]339 124774
      Parkinson's disease (PD), one of the most common neurodegenerative disorders, is characterized by mitochondrial dysfunction, neuroinflammation, and dopaminergic neuronal loss. Mitochondrial transplantation has emerged as a potential therapeutic strategy to treat various diseases with highly unmet needs. However, its application to brain diseases is limited by inefficient delivery across the blood-brain barrier (BBB). In this study, we engineered mitochondria to express a single-chain variable fragment against insulin-like growth factor 1 receptor on the outer mitochondrial membrane to enhance brain delivery. Surface engineering preserved mitochondrial functional integrity while significantly enhancing BBB transport in vitro. Following intravenous administration, human-specific mitochondrial DNA tracing demonstrated greater delivery of engineered mitochondria to the whole brain, striatum, and substantia nigra than naïve mitochondria. Functionally, they mitigated PD-relevant neurotoxin-induced damage, suppressed lipopolysaccharide-induced microglial activation and inflammation, and restored mitochondrial dysfunction. In a 6-hydroxydopamine-induced PD mouse model, engineered mitochondrial transplantation improved motor deficits, increased dopaminergic neuron survival, and reduced microgliosis, compared with naïve mitochondrial transplantation. Furthermore, engineered mitochondria promoted the expression of dopaminergic genes by activating nuclear receptor subfamily 4 group A member 2. Together, these findings demonstrate that engineered mitochondria represent a promising strategy to overcome BBB limitations and provide a novel therapeutic approach for PD.
    Keywords:  Blood-brain barrier; Mitochondrial transplantation; Neuroinflammation; Neuroprotective; Parkinson's disease
    DOI:  https://doi.org/10.1016/j.biomaterials.2026.124774
  46. Methods Mol Biol. 2027 ;3104 359-367
      Dopaminergic (DA) neurons regulate various physiological functions, including motor function, emotion, learning, sleep, and arousal. Degeneration of DA neurons in the substantia nigra of the midbrain causes motor disturbance in Parkinson's disease (PD). Studies on familial PD have revealed that a subset of PD genes encode proteins that regulate mitochondrial function and synaptic dynamics. Drosophila is a powerful model of PD, whereby genetic interactions of PD genes with well-conserved cellular signaling can be evaluated. Morphological changes in mitochondria, along with dysfunction and degeneration of DA neurons, have been reported in many studies using Drosophila PD models. In this chapter, we will describe imaging methods to visualize mitochondria in DA neurons and to evaluate spontaneous neural activity of DA neurons in the Drosophila brain.
    Keywords:  Dopaminergic neuron; Drosophila; Immunohistochemistry; Live imaging; Mitochondria; Synaptic vesicle release; pHluorin
    DOI:  https://doi.org/10.1007/978-1-0716-5699-0_31
  47. EMBO Mol Med. 2026 Nov 14.
      Mitophagy is critical for maintaining mitochondrial integrity and liver homeostasis, yet the specific microbial signals that regulate this process are poorly defined. Here, we identify bacterial peptidoglycan (PGN), a ubiquitous component of the bacterial cell wall, as a microbial signal that activates hepatocyte mitophagy and protects against liver fibrosis. PGN is internalized by hepatocytes and associates with mitochondria, where it engages the autophagic adaptor p62 (SQSTM1) to promote mitophagy. Hepatocyte-specific loss of p62 completely abolished PGN-induced mitophagy, establishing p62 as an essential mediator of this microbial response. Functionally, PGN-induced mitophagy protected hepatocytes from drug-induced cell death in vitro and in vivo, PGN administration reduced collagen deposition and hepatic stellate cell activation in a CCL4-induced model of liver fibrosis. These findings reveal a direct functional link between a bacterial cell-wall component and hepatocyte mitochondrial quality control, uncovering a previously unrecognized gut microbiota-mitophagy axis. Thus, PGN-mediated activation of hepatocyte mitophagy represents a potential strategy for restoring mitochondrial homeostasis and limiting fibrotic liver injury.
    DOI:  https://doi.org/10.1038/s44321-026-00548-9
  48. Int J Nanomedicine. 2026 ;21 648741
      Ischemia-reperfusion injury (IRI) remains a devastating clinical challenge across vital organs, including the heart, brain, kidneys, and liver. Irreversible tissue damage in this pathology is driven by mitochondrial dysfunction resulting from the catastrophic collapse of the mitochondrial quality control (MQC) network. Currently, no specific pharmacological therapy directly counteracts reperfusion-mediated secondary injury, and existing mitochondrial-regulating agents are severely limited by poor bioavailability, insufficient tissue selectivity, and membrane potential-dependent accumulation, highlighting an urgent need for precise delivery systems. Mitochondria-targeted nanomedicines have emerged as a promising preclinical strategy to overcome these barriers, enabling enrichment in ischemic tissues and subcellular delivery to mitochondria. Yet mitochondrial accumulation and functional effects must be validated for nanocarriers to qualify as mitochondria-targeted nanomedicines. Notably, a major bottleneck for current designs is that membrane potential-dependent systems, particularly triphenylphosphonium-based nanocarriers, show reduced mitochondrial accumulation in depolarized or severely damaged mitochondria under IRI conditions. To circumvent this drawback, diverse voltage-independent targeting strategies have been developed, and have successfully demonstrated the capacity to mitigate oxidative stress, restore mitochondrial homeostasis, and facilitate tissue repair in preclinical studies of myocardial, cerebral, renal, and hepatic IRI. This review elaborates the conserved pathological mechanisms of MQC dysfunction in IRI and critically evaluates the design principles of mitochondria-targeted nanocarriers. We further summarize recent advances in nanomaterial-based therapies targeting specific MQC nodes, including ER-mitochondria calcium crosstalk, fission-fusion dynamics, mitophagy, and biogenesis, alongside their organ-specific therapeutic applications. Finally, we discuss current translational bottlenecks and outline future directions to bridge the gap between preclinical success and clinical practice.
    Keywords:  ischemia-reperfusion injury; mitochondria-targeted nanotechnology; mitochondrial quality control; nanomedicine
    DOI:  https://doi.org/10.2147/IJN.S648741
  49. Methods Cell Biol. 2026 ;pii: S0091-679X(26)00190-1. [Epub ahead of print]211 113-143
      Mitochondria are indispensable organelles in the center of cellular bioenergetics, coupling oxidative phosphorylation to ATP production while also influencing processes such as cellular metabolism, oxidative stress regulation, reactive oxygen species (ROS) signaling, calcium buffering and apoptosis induction. Mitochondrial plasticity and remodeling shape the processes of cell differentiation, immune activation, senescence, and cancerogenesis. Their functional state is shaped by dynamic remodeling and frequently altered by pharmacological treatments, genetic mutations, aging, and cell dysfunction in association with diseases. Key parameters reflecting mitochondrial status include membrane potential (MMP), mitochondrial reactive oxygen species (mitoROS) and mitochondrial biomass. Here, we describe a unified, flow cytometry-based protocol for sequential quantification of these parameters in a single cell preparation using three fluorescent probes: MitoTracker Green FM for mitochondrial biomass, JC-1 for ratiometric measurement of MMP, and MitoSOX Red for mitoROS. The method is compatible with both adherent and suspension cells, provides single-cell resolution, and enables high-throughput profiling across high number of conditions and treatments. We demonstrate its utility in colorectal cancer cell lines with contrasting metabolic phenotypes (OXPHOS-reliant SW1417 and glycolytic COLO-320) exposed to chemotherapeutics and metabolic inhibitors. This parallel assay provides an efficient and scalable approach to interrogate mitochondrial functionality under diverse conditions. It is particularly valuable for studies of metabolic remodeling and cell stress responses, offering a practical alternative or complement to respirometry-based assays.
    Keywords:  Cell death; MMP; Mitochondria; OXPHOS; ROS
    DOI:  https://doi.org/10.1016/bs.mcb.2026.05.022
  50. Biomed Khim. 2026 Nov;72(5): 349-361
      Autism spectrum disorders (ASD) are a heterogeneous group of conditions in which neuroinflammation, systemic inflammation, and impaired mitochondrial energy function (mitochondrial dysfunction) serve as interconnected pathogenetic factors. Using organic acids profiling in urine it is possible to assess metabolic alterations related to glycolysis, the tricarboxylic acid (TCA) cycle, fatty acid β-oxidation, ketogenesis, branched-chain amino acid (BCAA) catabolism, and coenzyme Q10 metabolism. In this study we have analyzed 26 such metabolites in children with ASD and a control group of neurotypical children. The objective was to identify and characterize metabolic variants of mitochondrial dysfunction in ASD children and to evaluate the impact of the microbiota to the urinary organic acid profile. This single-center, observational, cross-sectional study included 105 ASD children (aged 3-9 years) and 95 conditionally healthy, neurotypical children, matched for age and sex. Urinary organic acids were measured using gas chromatography-mass spectrometry (GC-MS). Children with ASD exhibited diverse, bidirectional alterations in metabolites associated with energy metabolism. In the overall clinical group, there were elevated levels of pyruvic, cis-aconitic, isocitric, fumaric, and sebacic acids, as well as several intermediates of BCAA catabolism, and decreased levels of 2-ketoglutaric and succinic acids. Cluster analysis resulted in the identification of two distinct metabolic variants. The first cluster included 58 children and was characterized by the hyperexcretion of most organic acids, a pronounced alteration in TCA cycle markers, elevated meglutol levels, and a higher density within the metabolic correlation network. The second cluster, comprising 47 children, showed a metabolic profile similar to that of the control group, with reduced excretion of several key metabolites - primarily those associated with the TCA cycle and coenzyme Q10 metabolism. The primary contributors to the separation between these clusters were cis-aconitic, isocitric, citric, 2-ketoglutaric, malic, and fumaric acids, as well as meglutol. Urinary organic acids profiling enabled the identification of two patterns of metabolic dysregulation: hyperexcretory and hypoexcretory. These patterns reflect varying states of mitochondrial dysfunction, ranging from compensatory to subcompensated or decompensated. Subsequent comparison of the identified patterns of metabolic dysregulation with the functional status of mitochondria requires longitudinal monitoring of clinical condition of patients and also the assessment of inflammatory markers, such as pro-inflammatory cytokines, quinolinic acid, and kynurenic acid.
    Keywords:  autism spectrum disorder; metabolites; mitochondrial dysfunction; urinary organic acids
    DOI:  https://doi.org/10.18097/PBMCR1702
  51. Methods Mol Biol. 2027 ;3104 411-422
      Gene burden testing is a practical analytic framework for evaluating whether multiple rare variants within a gene, transcript, or biologically defined variant set are collectively associated with disease. This strategy is especially useful in rare disease and sequencing-based genetic studies because most individual rare variants are too uncommon to achieve adequate statistical power on their own, whereas aggregating them into a biologically meaningful set can increase the ability to detect association. This chapter is written as a general bioinformatics method rather than as a disease-specific protocol, so that it can be applied to Mendelian disorders, complex diseases enriched for rare coding alleles, unresolved exome cases, and candidate genes prioritized from wet-lab experiments. The workflow covers study design, data preparation, sample and variant quality control, variant annotation, definition of qualifying variants, selection of burden and kernel-based tests, covariate adjustment, and interpretation of positive and negative findings. Emphasis is placed on methods that are accessible to graduate students and physician-scientists using public or institutional sequencing datasets, and on practical decisions that strongly influence reproducibility, such as ancestry matching, allele-frequency thresholds, phenotype handling, and sensitivity analyses. The chapter also positions gene burden testing within the broader landscape of modern statistical genetics, including collapsing methods, weighted burden tests, variance-component methods, and extensions toward oligogenic or digenic disease architectures.
    Keywords:  CMC; Collapsing analysis; Exome sequencing; Gene burden test; Rare disease; Rare variants; SKAT; SKAT-O; Statistical genetics; Variant annotation
    DOI:  https://doi.org/10.1007/978-1-0716-5699-0_36
  52. Inflamm Bowel Dis. 2026 Nov 17. pii: izag237. [Epub ahead of print]
      Inflammatory bowel disease is a chronic inflammatory disease characterized by mucosal immunity dysregulation, epithelial barrier dysfunction, and gut microbiome dysbiosis. While cytokine-targeted therapies have improved clinical outcomes, many patients remain refractory or relapse, emphasizing the need for additional therapeutic approaches. Recent evidence suggests that mitochondrial metabolism in the intestinal epithelium regulates mucosal homeostasis, immune cell recruitment, and susceptibility to inflammation. However, it remains controversial whether mitochondrial dysfunction is a cause or a consequence of intestinal inflammation. Epithelial energetic deficiency and barrier dysfunction are associated with impaired oxidative phosphorylation, defective short-chain fatty acid utilization, redox imbalance, and faulty mitochondrial quality control. Indeed, impaired mitophagy promotes mitochondrial DNA (mtDNA) release through voltage-dependent anion channel 1 (VDAC1) oligomerization and mitochondrial permeability transition pore opening. Extracellular mtDNA acts as a damage-associated molecular pattern, activating cyclic GMP-AMP synthase-stimulator of interferon genes, toll-like receptor 9, and NLR family pyrin domain-containing 3 inflammasome pathways that amplify mucosal inflammation. These metabolic changes alter luminal oxygen and microbiome composition, whereas microbial metabolites, particularly tryptophan-derived indoles and kynurenines, modulate epithelial mitochondrial function through aryl hydrocarbon receptor signaling. These findings support a bidirectional microbiome-mitochondria-immune axis that potentiates intestinal inflammation. In this review, we summarize the current evidence of how epithelial mitochondrial dysfunction associates with intestinal inflammation. We discuss how mitochondrial metabolism interfaces with microbial ecology and immune regulation to shape disease pathogenesis. We also discuss therapeutic strategies targeting this axis: mitochondrial-targeted antioxidants (eg, MitoQ), VDAC1 inhibitors, bile-acid derivatives (eg, tauroursodeoxycholic acid), and metabolite-based therapies to restore microbial tryptophan metabolism. These approaches target mitochondrial bioenergetics and microbial metabolic cross-talk with the potential to restore microbiome-immune homeostasis, preserve barrier integrity, and complement conventional immune-directed therapies.
    Keywords:  epithelial bioenergetics; immunometabolism; inflammatory bowel disease; microbiome-mitochondria-immune axis; mitochondrial quality control; tryptophan metabolism
    DOI:  https://doi.org/10.1093/ibd/izag237
  53. Transl Psychiatry. 2026 Nov 20. pii: 661. [Epub ahead of print]16(1):
      Mitochondrial dysfunction is increasingly implicated in psychiatric disorders, yet the regulatory mechanisms linking brain-expressed mitochondrial genes to disease risk remain unclear. To investigate these mechanisms, we employed an integrative multi-omics approach combining brain-derived DNA methylation, gene expression, and protein abundance quantitative trait locus (QTL) datasets to evaluate genetically predicted associations of mitochondria related molecular traits with schizophrenia (SCZ), bipolar disorder (BD), major depressive disorder (MDD), cross-disorder phenotypes, and clinical subtypes. Summary-data-based Mendelian randomization (SMR), Heterogeneity in dependent instruments (HEIDI) testing, and Bayesian colocalization analyses were applied, followed by a study-specific three-tier framework to prioritize potential putative causal genes. Our  analyses prioritized ACADVL and SLC25A24 as Tier 1 genes for SCZ, COX11 as a Tier 2 gene for SCZ, and DLST, ENDOG, and PDF as Tier 3 genes for SCZ. ENDOG and PDF were also prioritized for the BD-SCZ cross-disorder phenotype. Further SMR analyses across molecular layers supported ENDOG as a methylation-linked regulatory signal, whereas expression-to-protein associations for COX11 and SLC25A24 showed colocalization support but did not meet the HEIDI criterion. Single-cell analyses suggested context-dependent ENDOG effects across immune cell types. Together, these findings support the involvement of mitochondria-related genes across molecular layers in psychiatric disorders and identify genetically supported candidate genes that warrant experimental validation.
    DOI:  https://doi.org/10.1038/s41398-026-04586-2
  54. Mol Med. 2026 Nov 17. pii: 228. [Epub ahead of print]32(1):
       BACKGROUND: Cerebral palsy (CP) is associated with progressive skeletal muscle weakness and reduced physical capacity, yet the contribution of mitochondrial dysfunction to these impairments remains incompletely understood.
    METHODS: We therefore evaluated skeletal muscle mitochondrial health in children with CP and typically developing (TD) children (12.9±3.4years) using a comprehensive approach integrating high-resolution respirometry, targeted protein analyses, circulating biomarkers, and plasma proteomics. Thirty-six skeletal muscle biopsies from 22 children with CP, and 15 muscle biopsies from TD children were collected during planned orthopedic surgery.
    RESULTS: Skeletal muscle from children with CP exhibited markedly reduced oxidative capacity (-50% in CP vs TD, p<0.001), accompanied by broad reductions in mitochondrial and substrate transport proteins suggesting reduced mitochondrial content. Despite the absence of local or systemic inflammation, circulating growth differentiation factor-15 (GDF-15), a biomarker of mitochondrial distress, was elevated in children with CP (337±53 vs 626±547pg·ml-1 for TD vs CP, p<0.05) and was highest among those with more severe motor impairments.
    CONCLUSION: These findings demonstrate that previously reported reductions in skeletal muscle mitochondrial protein content in CP translate into profound impairments in mitochondrial function. Moreover, the dissociation between mitochondrial dysfunction and inflammatory signaling suggests that mitochondrial insufficiency in CP occurs independently of inflammation. Elevated circulating GDF-15 further suggests that mitochondrial dysfunction in CP may extend beyond skeletal muscle and exert systemic effects. Together, our findings identify mitochondrial insufficiency as a prominent feature of skeletal muscle pathology in CP potentially acting as a contributor to secondary health complications across the lifespan.
    Keywords:  Cerebral palsy; ELISA; GDF-15; Mitochondria; Muscle fibers; OXPHOS; Olink; Respiration; Western blot
    DOI:  https://doi.org/10.1186/s10020-026-01700-4
  55. EMBO J. 2026 Nov 20.
      Autosomal recessive mutations in the Parkin gene (PRKN) cause early-onset Parkinson's disease (PD). Parkin functions as a ubiquitin E3 ligase acting downstream of the PINK1 kinase to promote phosphorylated ubiquitin at sites of mitochondrial damage. Yet the functional effects of most PRKN gene variants remain unknown. Here, we use a pooled cellular assay measuring phosphorylated ubiquitin accumulation to quantify the activity of ~9200 PRKN missense and nonsense variants. Our screen identifies thousands of loss- and gain-of-function variants, including activating variants mainly residing at autoinhibitory interfaces. Functional scores accurately distinguish known PD pathogenic and benign variants, providing evidence of pathogenicity or benignity for 175/182 variants of uncertain significance (VUS). When combined into biallelic genotype scores, these data predict the age at disease onset in patients, revealing a quantitative link between Parkin activity and clinical manifestation. Our results provide a comprehensive functional genetic map of Parkin and demonstrate the power of multiplexed assays of variant effects (MAVEs) for variant interpretation and precision medicine in PD.
    DOI:  https://doi.org/10.1038/s44318-026-00960-4
  56. Int J Gen Med. 2026 ;19 661206
      Mitochondrial quality-control failure contributes to cardiovascular injury, but the consequences of mitophagy depend on the nature and timing of stress. FUN14 domain-containing protein 1 (FUNDC1) is an outer mitochondrial membrane mitophagy receptor that also regulates mitochondrial dynamics, mitochondria-endoplasmic reticulum contacts, and Ca2⁺ homeostasis. This review synthesizes the regulation of FUNDC1 and critically examines its context-dependent effects in myocardial ischemia/reperfusion injury (MIRI), heart failure and myocardial remodeling, and metabolic cardiomyopathy. In several MIRI and heart-failure models, impaired FUNDC1-associated mitochondrial quality control is linked to injury, whereas excessive or mistimed FUNDC1-associated mitophagy may be detrimental in selected reperfusion and pulmonary vascular settings. In metabolic cardiomyopathy, hyperglycemia-associated FUNDC1-IP3R2 signaling promotes abnormal organelle contacts and mitochondrial Ca2⁺ overload, whereas FUNDC1 deficiency during lipid overload is linked to mitochondrial damage and heightened lipotoxic susceptibility. These apparently divergent effects may reflect differences in cellular context, stress exposure, disease stage, and mitophagy-independent FUNDC1 functions; however, the underlying causal mechanisms remain incompletely defined. We highlight inconsistencies among experimental models and distinguish evidence from direct mitophagy-flux measurements from conclusions based on indirect markers. Given the predominance of preclinical evidence, further mechanistic and translational studies are needed before FUNDC1-directed therapies can be considered for clinical use.
    Keywords:  FUNDC1; cardiovascular disease; mitochondria-associated endoplasmic reticulum membranes; mitochondrial homeostasis; mitochondrial quality control; mitophagy
    DOI:  https://doi.org/10.2147/IJGM.S661206
  57. Geroscience. 2026 Nov 19.
      Mitochondria-endoplasmic reticulum contact sites (MERCs) are critical structural hubs that integrate cellular signaling, bioenergetics and proteostasis. In skeletal muscle, a tissue exceptionally vulnerable to age-related decline, MERCs physically and functionally link mitochondria with the sarcoplasmic reticulum (SR), with mitochondria to govern excitation-contraction coupling, coordinating calcium (Ca2+) homeostasis and metabolic homeostasis. While Sarcopenia (age-related muscle loss) and anabolic resistance-the blunted hypertrophic response to nutrition or contractile stimuli, have traditionally been attributed to factors such as mitochondrial dysfunction, hormonal shifts, and chronic low-grade inflammation, growing evidence positions MERCs as a spatial nexus where these pathogenic processes converge. This review examines fundamental biology of muscle MERCs, detailing their specialized molecular architecture, tethering complexes, and physiological roles in Ca2+ dynamics, bioenergetics, and proteostasis. We then evaluate how aging perturbs MERC ultrastructure characterized by the loss of structural tethers and progressive widening of SR-mitochondrial gaps and discuss how these changes are not merely correlative but are potentially mechanistically linked to impaired anabolic signaling. Specifically, we synthesize structural and molecular evidence illustrating how age-associated contact deterioration uncouples excitation-metabolism signaling, tipping myofibers into local energetic shortfalls and blunting translational control. Furthermore, we connect this loss of organellar coordination to quantifiable functional deficits, including slowed relaxation kinetics, impaired metabolic flexibility, and suppressed hypertrophic responsiveness. Finally, we explore potential emerging countermeasures aimed at stabilizing ER-mitochondrial coupling, spanning exercise, dietary compounds, and pharmacological stabilizers alongside translational perspectives across species, muscle types. Collectively, muscle MERCs emerge as a unifying mechanistic node in sarcopenia, linking nanoscale architecture to cellular energetic, anabolic resistance, and muscle longevity.
    Keywords:  Aging; MAM; MERC; Sarcopenia; Skeletal muscle
    DOI:  https://doi.org/10.1007/s11357-026-02653-6
  58. Nat Commun. 2026 10 17. pii: 11711. [Epub ahead of print]17(1):
      Fatty acid (FA) availability for brown adipose tissue (BAT) thermogenesis depends in part on lipolysis of lipid droplet (LD) triglycerides. Here, we identify the membrane adaptor ankyrin-B (AnkB), encoded by the cardiometabolic disease-associated ANK2 gene, as a regulator of brown adipocyte lipid homeostasis and metabolic adaptation. BAT-specific AnkB deficiency caused excess lipid accumulation, enlarged LDs, and BAT whitening without altering mitochondrial oxidative capacity or thermogenesis in the fed state in male mice. Mechanistically, AnkB promoted basal lipolysis by recruiting hormone-sensitive lipase to LDs. However, AnkB loss compromised thermoregulation during cold exposure with fasting, linking AnkB-dependent FA release to thermogenesis under energetic stress. Unexpectedly, BAT AnkB deficiency protected male mice from high-fat diet-induced obesity (DIO), hepatic steatosis, glucose intolerance, and insulin resistance. This protection was associated with enhanced BAT mitochondrial oxidative capacity, oxidative remodeling of white adipose tissue, and increased circulating FGF21. Together, these findings establish AnkB as a previously unrecognized regulator of BAT lipid mobilization that coordinates thermogenic fuel availability with mitochondrial oxidative adaptation during metabolic stress.
    DOI:  https://doi.org/10.1038/s41467-026-78907-w
  59. Cell Commun Signal. 2026 Aug 21. pii: 612. [Epub ahead of print]24(1):
       BACKGROUND: The scarcity of functional transplantable pancreatic islets remains a central limitation for curative cell replacement therapies for diabetes. Although human pluripotent stem cells provide a theoretically unlimited source of β cells, intrinsic metabolic constraints that restrict efficient endocrine lineage commitment and functional maturation are poorly defined.
    METHODS: We combined metabolic pathway interrogation with functional and in vivo analyses to examine how mitochondrial redox signaling influences endocrine specification during human pluripotent stem cell differentiation. Targeted modulation of mitochondrial reactive oxygen species-linked arachidonic acid and eicosanoid metabolism was used to assess its impact on β-cell differentiation, maturation, and therapeutic performance following transplantation.
    RESULTS: We identify a previously unrecognized mitochondrial reactive oxygen species-driven arachidonic acid/12-hydroxyeicosatetraenoic acid metabolic axis that functions as a metabolic checkpoint limiting endocrine lineage commitment. Disruption of this pathway markedly enhances the generation of stem cell-derived β cells and accelerates their functional maturation, resulting in improved glucose-responsive insulin secretion in vitro. Notably, β cells produced through this metabolic reprogramming strategy restore normoglycaemia more rapidly and robustly after transplantation into diabetic mice than cells generated using conventional differentiation protocols.
    CONCLUSIONS: These findings define a mechanistic link between mitochondrial redox signaling and eicosanoid metabolism in β-cell fate control and establish metabolic pathway engineering as a powerful strategy to improve the efficacy of stem cell-based islet replacement therapies for diabetes.
    Keywords:  12-hydroxyeicosatetraenoic acid; Arachidonic acid; Endocrine differentiation; Mitochondrial metabolism; Pluripotent stem cell
    DOI:  https://doi.org/10.1186/s12964-026-03169-4
  60. Immunol Res. 2026 Nov 19. pii: 147. [Epub ahead of print]74(1):
      Knee osteoarthritis (KOA) is a chronic degenerative disease characterized primarily by chondrocyte senescence. Despite substantial progress in understanding the underlying degenerative pathology in recent years, effective clinical therapeutic strategies for KOA remain urgently needed. Accumulating evidence indicates that mitochondrial damage-manifested by elevated intracellular reactive oxygen species (ROS) and the release of mitochondrial DNA (mtDNA)-is a critical driver of chondrocyte senescence. Mitophagy, a core mechanism of mitochondrial quality control, selectively eliminates damaged and dysfunctional mitochondria, thereby reducing cytoplasmic ROS levels and regulating mtDNA release, ultimately retarding cellular senescence. Therefore, elucidating the molecular mechanisms by which mitophagy is induced to alleviate chondrocyte senescence holds significant therapeutic promise for KOA. Based on a comprehensive review of the literature, we propose the central hypothesis that SIRT6, through deacetylation of Parkin, enhances its E3 ubiquitin ligase activity, thereby activating the PINK1/Parkin pathway‑mediated mitophagy. This promotes the timely clearance of damaged mitochondria and subsequently alleviates chondrocyte senescence. This review suggests that targeting SIRT6 to modulate mitophagy may serve as a critical link between molecular regulation and cellular homeostasis, offering a novel avenue for the clinical prevention and treatment of KOA.
    Keywords:  Chondrocyte senescence; Mitophagy; Osteoarthritis; Reactive oxygen species; Sirt6
    DOI:  https://doi.org/10.1007/s12026-026-09882-z
  61. Front Immunol. 2026 ;17 1991494
      Mitoxyperilysis is a proposed lytic death pathway in which oxidatively damaged mitochondria become membrane-lethal when retained at the plasma membrane. In founding models, TLR stimulation plus carbon restriction engaged MYD88-dependent innate signalling and BAX/BAK1/BID-dependent mitochondrial oxidative stress, while mTORC2-RhoA-actin remodelling prolonged peripheral mitochondrial retention. Mitoxyperiosis denotes prolonged mitochondria-plasma membrane association and localised oxidative membrane injury, whereas mitoxyperilysis denotes the subsequent plasma membrane rupture and lytic cell death. In these models, NINJ1 contributed to terminal rupture and LDH/HMGB1 release without being required for cell death. The damaging oxidant, physical tether, and mechanism linking local injury to membrane failure remain unresolved. Sepsis may reproduce upstream metabolic-redox conditions, but direct evidence for the complete spatial sequence in patient-derived cells is lacking. This review separates founding-model findings from disease-relevant observations and untested steps.
    Keywords:  NINJ1; immunometabolism; mitochondrial oxidative stress; mitochondria–plasma membrane contact; mitoxyperilysis; mitoxyperiosis; sepsis
    DOI:  https://doi.org/10.3389/fimmu.2026.1991494
  62. Toxicol Sci. 2026 Nov 14. pii: kfag155. [Epub ahead of print]
      People are widely exposed to the antimicrobial cetylpyridinium chloride (CPC) via consumer products, but CPC is a mitochondrial toxicant with potency comparable to that of canonical mitotoxicants. CPC is largely unregulated despite growing usage, bioavailability, and ability to cross the blood-brain barrier. Previously, we showed, in several cell types at non-cytotoxic and exposure-relevant doses, CPC inhibits ATP and oxygen consumption rate. Mitochondrial toxicity is linked to multiple diseases, but CPC has not been studied epidemiologically, and its mode of action is unknown. To determine why oxygen consumption is hampered by CPC, we hypothesized that CPC inhibits electron transport chain components, cardiolipin, or Krebs cycle enzymes. Here, we show that, in primary human skin cells, an immune mast cell model, and isolated mitochondria, CPC apparently inhibits multiple electron transport chain Complexes. Detailed investigation pinpointed the mechanism to the distal end of electron transport chain: Complex III-cytochrome c-Complex IV. Using multiple approaches, we show that CPC does not directly inhibit any of the Complexes, nor Krebs enzymes, nor coenzyme Q. Yet, CPC exhibits mitotoxicity with potency comparable to cyanide. In healthy mitochondria, the lipid cardiolipin attracts cytochrome c so that it may shuttle electrons from Complex III to IV. We present evidence implicating electrostatic CPC interference in cardiolipin-cytochrome c interactions. To provide data for focusing epidemiological investigations, clarifying risk analysis, and positing new mechanisms of action for predictive toxicology, we determined the biochemical mechanism of action of this ubiquitous chemical, a model for the large class of quaternary ammonium compounds.
    Keywords:  cardiolipin; cetylpyridinium chloride; cytochrome c; electron transport chain; mitochondrial toxicant; quaternary ammonium compound
    DOI:  https://doi.org/10.1093/toxsci/kfag155
  63. Biochem Pharmacol. 2026 Nov 17. pii: S0006-2952(26)01011-7. [Epub ahead of print]255 118668
      Dynamin-related protein 1 (Drp1) is a mechanoenzyme that moves between autoinhibited, receptor-bound, oligomeric and membrane-constricting states. This structural plasticity creates several pharmacological opportunities, but it also limits the interpretation of mitochondrial division inhibitor 1 (Mdivi-1), the most widely used fission-modulating compound in cardiovascular research. We integrate experimental Drp1 structures with biochemical pharmacology, cell-specific cardiovascular biology and translational evidence. A ligand-bound Drp1 structure (Protein Data Bank entry 8SKN) provided a positive-control pocket for an exploratory docking analysis. Redocking of the co-crystal ligand failed in a dry preparation (0/20 seeds) but succeeded after four crystallographic waters were retained (20/20; median top-three root-mean-square deviation, 0.83 Å). Three prespecified Mdivi-1 tautomers then produced reproducible poses in this pocket, although their median Vina scores were 2.11-2.39 kcal/mol less favorable than that of the co-crystal ligand. These calculations support geometric compatibility under one validated preparation; they do not establish direct binding, inhibition or selectivity. Mdivi-1 also affects complex I, respiratory supercomplexes, redox state, autophagic flux, calcium handling and cardiovascular ion channels. Drp1 itself supports both injurious fragmentation and adaptive quality control, with outcomes that vary by cell type and disease phase. Structure, exposure and cellular context together inform the cardiovascular response. Mdivi-1 remains a useful mechanistic probe whose contribution to Drp1-dependent function is clarified through target engagement and independent causal evidence.
    Keywords:  Cardiovascular pharmacology; Drp1; Mdivi-1; Mitochondrial fission; Structural pharmacology; Target engagement
    DOI:  https://doi.org/10.1016/j.bcp.2026.118668
  64. Clin Genet. 2026 Nov 18.
      Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is an autosomal recessive disorder of mitochondrial fatty acid β-oxidation caused by biallelic pathogenic variants in ACADVL. Its most severe form, the cardiomyopathic phenotype, presents early, progresses rapidly, and carries high mortality; yet quantitative tools for early risk stratification are lacking. We conducted a systematic review and pooled analysis of 213 published VLCADD cases to investigate the associations of age at onset, acylcarnitine profiles, and ACADVL variant types with the cardiomyopathic phenotype. Univariate analysis showed that log-transformed age at onset, C14 acylcarnitine levels, and variant type differed significantly between the cardiomyopathic and noncardiomyopathic groups, whereas sex and C14:1 level did not. Age at onset demonstrated excellent discriminative ability (area under the curve 0.90; optimal cutoff 5.48 months, sensitivity 88.3%, specificity 83.7%). A clear genotype-phenotype gradient was observed, with carriers of two loss-of-function (LOF) variants showing the highest risk. In conclusion, age at onset is the most robust and discriminative marker of the cardiomyopathic phenotype, and two LOF variants identify a high-risk subgroup. These findings support early risk stratification and targeted cardiac surveillance in VLCADD.
    Keywords:  ACADVL variant; VLCADD; acylcarnitine; age of onset; rare disease
    DOI:  https://doi.org/10.1111/cge.70282